Company: ZVRA
Filing Date: 2025-04-21
Form Type: DEFC14A
Source: 0001193125-25-086293
Chunk: 71

Company: ZEVRA THERAPEUTICS, INC.
Filing Date: 2025-04-21
Form: DEFC14A
Chunk 71
---
 |                                                                                 5.26 |     |                                                       2,621,000 |
| Total                                                         |     |                                        7,789,658 |     |                                                                                      |     |                                                       6,531,177 |

| (1) | Includes (i) options to purchase a total of 100 shares of our common stock under the 2007 Plan, (ii) options to purchase a total of 4,651,300 shares of common stock under the 2014 Plan and (iii) 1,309,258 restricted stock units under our 2014 Plan. Restricted stock units do not have an exercise price and were not included in calculating weighted average exercise prices. |

| (2) | Consists of 2,762,165 shares of common stock reserved for issuance under the 2014 Plan and 1,148,012 shares of common stock reserved for issuance under the 2021 ESPP. The number of shares of our common stock reserved for issuance under the 2014 Plan will automatically increase each year on January 1 from January 1, 2016, continuing through January 1, 2031, by (i) 4.0% of the total number of shares of our common stock outstanding on December 31 of the preceding calendar year, or (ii) a lesser number of shares determined by our Board. Pursuant to the terms of the 2014 Plan, an additional 2,146,828 shares of common stock were added to the number of shares reserved for issuance under the 2014 Plan, effective January 1, 2025. |

| (3) | Consists of the 2023 Plan. For a summary of the 2023 Plan, see Note M to our audited consolidated financial statements included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024. |

| (4) | Includes (i) options to purchase a total of 1,300,000 shares of our common stock under the 2023 Plan, and (ii) 529,000 restricted stock units under our 2023 Plan. Restricted stock units do not have an exercise price and were not included in calculating weighted average exercise prices. |

72

RELATED-PERSONTRANSACTIONS POLICY AND PROCEDURES We have a related-persontransaction policy in writing that sets forth our procedures for the identification, review, consideration and approval or ratification of related-persontransactions. For purposes of our policy only